A
RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY FOLLOWED BY OPEN-LABEL
TREATMENT OF ALTO-100 IN ADULTS WITH BIPOLAR DISORDER CURRENTLY EXPERIENCING A MAJOR
DEPRESSIVE EPISODE
Double-Blind, Randomized Placebo-Controlled Study to Evaluate
Efficacy and Safety and the Maintenance of Effect of 20-mg Seltorexant as Adjunctive Therapy
to Antidepressants in Adult and Elderly Patients with Major Depressive Disorder with Insomnia
Symptoms
Click to add your name to the waiting list for upcoming studies. We will alert you when we begin a new study. Please provide your email address if possible.
*PLEASE DO NOT CALL THE STUDY CENTER UNLESS YOU ARE CONTACTED FIRST*
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXTfor the Treatment of Psychosis Associated with Alzheimer’s Disease (ADEPT –4 )
Prevention of Gluten-Specific T Cell Activation in Subjects with Celiac Dis
The
ILLUMINATE-101 clinical research study is evaluating the safety and
effectiveness of an investigational medication designed to reduce or eliminate
the negative immune response to gluten in adults with celiac disease and
participants are needed.
Uterine Fibroids or Moderate to Severe Pain Associated with Endometriosis
Open-Label Study to Evaluate Bone Mineral Density with Long-Term Use of Relugolix Combination Tablet in Premenopausal Women with Heavy Menstrual Bleeding Associated with Uterine Fibroids or Moderate to Severe Pain Associated with Endometriosis
A Study to Evaluate the Safety and Efficacy of Flu Vaccine for Prevention o
A Novel Long-Acting Antiviral Conjugate, for the
Prevention of Influenza in Adults and Adolescents at Higher
Risk of Developing Influenza Complications
A Randomized, Placebo-controlled, Double-blind, Multicenter, 12‑Week, 3-Way, Partial-replicate Crossover Pharmacodynamic Study to Assess the Equivalence of Budesonide and Albuterol (BDA) Delivered by MDI HFO Compared with BDA Delivered by MDI HFA in Participants with Asthma